HOME >> MEDICINE >> NEWS
Advances In Translational Cancer Research Is Focus Of 90th Annual Meeting Of American Association For Cancer Research

Philadelphia, March 30, 1999 -- Cancer researchers from around the world will meet in April at the 90th Annual Meeting of American Association for Cancer Research (AACR) to share cutting-edge research findings in the rapidly advancing areas of translational research and molecular genetics, including anti-angiogenesis agents, cancer vaccines, gene therapy, and molecular targeted therapy. The meeting will take place from April 10-14 at the Pennsylvania Convention Center in Philadelphia, and will feature close to 5,000 abstracts and 200 invited presentations. Two special late-breaking research sessions will offer reports of highly significant and timely findings that have occurred within the last few months. A new feature at the Annual Meeting is a special lecture, given this year by Nobel Laureate James D. Watson, Ph.D., entitled "From the Double Helix to DNA Tumor Viruses."

"As the pace of scientific discovery accelerates, it is essential to present the most up-to-date and novel information to the scientific community and the public in order to make progress against cancer," said Webster K. Cavenee Ph.D., President of AACR and Director, Ludwig Institute for Cancer Research in La Jolla, CA. "To that end, we have been closely monitoring scientific developments and will present research on the latest research findings in all of the subdisciplines of cancer research."

"For the last five months, the 90th Annual Meeting Program Committee has been working to examine the entire field of cancer research and identify the most rapidly developing research areas, as well as the most appropriate scientists to organize the sessions in which these new data will be presented," said Waun Ki Hong, M.D., American Cancer Society Clinical Research Professor, Professor and Chairman, Department of Thoracic/Head and Neck Oncology, UT M.D. Anderson Cancer Center, Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, Chairperson of the AACR Program C
'"/>

Contact: Jack Cooley
jcooley@cwg.com
212-886-2200
Cooney Waters Group, Inc.
4-Apr-1999


Page: 1 2 3 4

Related medicine news :

1. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
2. Advances in plasma physics at Annual APS Meeting
3. Advances in plasma physics at Annual APS Meeting
4. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Advances emerging in hepatitis management
7. Advances in prevention and treatment research hold promise for pipeline
8. Advances in MRI imaging may lead to new standards for faster diagnosis of multiple sclerosis
9. Peanut Allergy: Major Advances in Treatment and Education
10. "Radical" Discovery Advances Medicine and Plastics
11. Advances in On the Spot tests have huge public health implications

Post Your Comments:
(Date:3/6/2015)... FCPX developers have announced a ... , “Pro3rd Hue is a lower 3rd pack with a ... Film Studios. “Blurring the line between professional and armature, Pro3rd ... a set of 30 customizable lower third presets made exclusively ... FCPX users can complement any design with a clean and ...
(Date:3/6/2015)... 06, 2015 Dr. Mark Sowell recently returned ... Scottsdale, AZ. Offering programs for advanced education in the field ... world. , As a visiting faculty member of this ... learn” each time he visits Spear Education to participate in ... remarks, “we are training only the top 10% and those ...
(Date:3/6/2015)... March 06, 2015 As the Mayo ... be discussed, Ford & Associates Nationwide Legal Services, A.P.C., ... 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case ... California. , “In light of a recently filed ... Benicar to evaluate and explore the Mayo Clinic's Benicar ...
(Date:3/5/2015)... 2015 In 2014, the FDA approved ... tops the list scoring 4 drug approvals in the ... all FDA approved drug products, followed by oncology therapy ... anti-PCSK9, anti-PD1 and CDK inhibitors keep on attracting large-cap ... FDA to treat metastatic melanoma, and at present, they ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... levels of formaldehyde in low-cost laminate flooring ... the leading manufacturer of eco-friendly building materials made ... customer safety by testing all their flooring products ... emissions detection laboratory Benchmark International (BMH). ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2
(Date:3/5/2015)... BAUDETTE, Minn. , March 5, 2015 /PRNewswire/ ... ) today announced that it has acquired the ... Acetate tablets USP 50mg, 100mg and 150mg, previously ... the overall market for this product was approximately ... Arthur S. Przybyl , President and CEO of ...
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) has announced ... Accelerating growth to the next level - Moving up ... offering. Domestic sales improved in 2014, ... the market,s reaction to the new drug pricing policy. ... healthy, as the momentum continues and improving economic growth ...
(Date:3/5/2015)... 2015 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing products that address unmet medical needs in the ... its President and Chief Executive Officer, Christopher J. ... the 27 th Annual ROTH Conference in ... 10, 2015 at 1:00 PM Pacific Daylight Time (PDT).  ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
Cached News: